Tags : Inhalation

Chiesi’s Bronchitol (mannitol) Inhalation Powder Receives the US FDA’s Approval

Tuba Khan November 19, 2020

Shots: In the three large-scale global clinical trials assessing Bronchitol in 761 patients, sustained improvement in FEV1 (Forced Expiratory Volume) with Bronchitol use vs. control group was observed Bronchitol is […]readmore

Pharma

Boehringer Ingelheim Reports Real-World Data for Spiriva Respimat (tiotropium bromide)

Vartika Singh February 4, 2020

Shots: The real-world data involves assessing of Spiriva Respima Inhalation Spray 1.25mcg + combination inhaled corticosteroid and long-acting beta2-agonist (ICS+LABA) vs increased dose of ICS+LABA or continuing high dose of […]readmore

Tags : Inhalation

Chiesi’s Bronchitol (mannitol) Inhalation Powder Receives the US FDA’s Approval

Boehringer Ingelheim Reports Real-World Data for Spiriva Respimat (tiotropium bromide)

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Inhalation

Chiesi’s Bronchitol (mannitol) Inhalation Powder Receives the US FDA’s Approval

Boehringer Ingelheim Reports Real-World Data for Spiriva Respimat (tiotropium bromide)

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company